CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: First report from Turkey

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 8, 2003, Pages 503-505

  Acikgoz, Ziya Cibali ^a   Gulay, Zeynep ^b   Bicmen, Meral ^b   Gocer, Safiye ^a   Gamberzade, Sohret ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; COTRIMOXAZOLE; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; FECES ANALYSIS; HUMAN; ISOELECTRIC FOCUSING; MALE; NONHUMAN; OUTPATIENT; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE ANALYSIS; SHIGELLA SONNEI; TURKEY (REPUBLIC);

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SHIGELLA SONNEI; TURKEY;

EID: 0141427852     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310013270     Document Type: Article

References (14)

1. Bradford PA. Extended spectrum β-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
2. Ahamed J, Kundu M. Molecular characterisation of the SHV-11 β-lactamase of Shigella dysenteriae. Antimicrob Agents Chemother 1999; 43: 2081-3.
3. Fortineau N, Naas T, Gaillot O, Nordmann P. SHV-type extended-spectrum β-lactamase in a Shigella sonnei clinical isolate. J Antimicrob Chemother 2001; 47: 685-8.
4. Pai H, Choi EH, Lee HJ, Hong JY, Jacoby G. Identification of CTX-M-14 extended spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 1960; 39: 3747-9.
5. Radice M, Gonzales C, Power P, Vidal MD, Gutkind G. Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg Infect Dis 2001; 7: 442-3.
6. Jarlier V, Nicoles MM, Fornier G, Philippon A. Extended broad spectrum. β-lactamases conferring resistance to newer beta-lactam agents in Enterobacteriacae; hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-71.
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. M7-A5. Vol. 20. No. 2. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. M2-A7. Vol. 20. No. 1. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
9. Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975; 88: 169-78.
10. Gniadowski M, Schneider I, Paucha A, Jungwirth R, Mikiewicz B, Bauernfeind A. Cefotaxime-resistant Enterobacteriaceae from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime hydrolysing β-lactamase that is closely related to CTX-M-1/MEN-1 enzyme. Antimicrob Agents 1998; 42: 827-32.
11. Voogd CE, Schot CS, van Leeuwen WJ, van Klingeren B. Monitoring of antibiotic resistance in Shigella isolated in the Netherlands 1984-1989. Eur J Clin Microbiol Infect Dis 1992; 11: 164-7.
12. Prats G, Mirelis B, Llovet T, Munoz C, Miro E, Navarro F. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob Agents Chemother 2000; 44: 1140-5.
13. Watanabe T, Fukasawa T. Episome-mediated transfer of drug resistance in Enterobacteriaceae. J Bacteriol 1960; 81: 669-78.
14. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. Vol. 17. No. 2. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997.